SBC Medical Group (SBC) Stock: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$5.09
0.02 (0.39%)
▲
5d:
+3.88%
30d:
+20.33%
90d:
+65.26%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SBC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SBC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.88
Based on 10.7% avg growth
INTRINSIC VALUE TODAY
$4.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $5.09, which is considered extended relative to its 30-day fair value range of $4.22 to $4.93. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.4) compared to its historical average (7.7). At these levels, the market is pricing in 7.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SBC is in a strong uptrend. Immediate support is located at $4.66, while resistance sits at $5.29.
Market Sentiment: SBC scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.75 (+71.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBC is in a strong uptrend. Immediate support is located at $4.66, while resistance sits at $5.29.
Market Sentiment: SBC scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.75 (+71.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.22 -
$4.93
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
28.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.9% below Wall St target ($8.75)
- NEUTRAL: PE elevated vs history but 7.0% growth expectation is conservative given 339% recent growth
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.22 -
$4.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.66
Resistance Level
$5.29
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.43
Wall Street Target
$8.75
(+71.9%)
Revenue Growth (YoY)
13.4%
Earnings Growth (YoY)
338.9%
Profit Margin
28.0%
Valuation Premium vs History
+7.0% premium
PE vs Historical
9.4 vs 7.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.0%
(market-implied from PE analysis)
1-Year Target
$5.45
(+7%)
2-Year Target
$5.83
(+15%)
3-Year Target
$6.24
(+23%)
3-Yr Target (if PE normalizes)
(PE: 9→8)
PE COMPRESSION
$5.09
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 17.4%)
$17.82
(+250%)
Base:
(SPY PE: 9.4, Growth: 17.4%)
$8.23
(+62%)
Bear:
(PE: 7.7, Growth: 17.4%)
$6.73
(+32%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 10.56 | Current EPS (TTM): $0.48
Bull Case
$6.27
(+23%)
Analyst growth 12.5%, PE expands to 11.6
Base Case
$5.70
(+12%)
Market implied 12.5%, PE stable at 10.6
Bear Case
$3.45
(-32%)
Severe decline -20.0%, PE contracts to 9.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 04, 2026 1:42 PM ET
Data refreshes hourly during market hours. Next update: 2:42 PM
Data refreshes hourly during market hours. Next update: 2:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
STRONG BUY
24 analysts |
$207 | 56 HOLD |
|
VRSK
Verisk Analytics Inc |
BUY
19 analysts |
$235 | 55 HOLD |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$191 | 60 HOLD |
|
ICFI
ICF International Inc |
STRONG BUY
5 analysts |
$107 | 67 BUY |
|
BAH
Booz Allen Hamilton Hold… |
SELL
15 analysts |
$85 | 45 HOLD |
